Tempus – A company that uses AI to gather and analyze clinical and molecular data for personalized cancer care.
Cancer is a complex disease that affects millions of people worldwide. Despite significant advances in cancer treatment, there is still a long way to go in terms of providing personalized care that is tailored to each patient’s unique needs. This is where Tempus comes in. Tempus is a company that uses artificial intelligence (AI) to gather and analyze clinical and molecular data for personalized cancer care.
Tempus was founded in 2015 by Eric Lefkofsky, a serial entrepreneur who co-founded Groupon.